Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1

  1. García-Fumero, R.
  2. Fernández-López, C.
  3. Calleja-Hernández, M.Á.
  4. Expósito-Hernández, J.
Aldizkaria:
Acta Oncologica

ISSN: 1651-226X 0284-186X

Argitalpen urtea: 2021

Alea: 60

Zenbakia: 9

Orrialdeak: 1225-1232

Mota: Artikulua

DOI: 10.1080/0284186X.2021.1942546 GOOGLE SCHOLAR